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Abstract 
Purpose: To study the association between early initiation of intra‑arrest therapeutic hypothermia and neurologic 
outcome in out‑of‑hospital cardiac arrest.
Methods: A prespecified sub‑analysis of the PRINCESS trial (NCT01400373) that randomized 677 bystander‑
witnessed cardiac arrests to transnasal evaporative intra‑arrest cooling initiated by emergency medical services or 
cooling started after hospital arrival. Early cooling (intervention) was defined as intra‑arrest cooling initiated < 20 min 
from collapse (i.e., ≤ median time to cooling in PRINCESS). Propensity score matching established comparable control 
patients. Primary outcome was favorable neurologic outcome, Cerebral Performance Category (CPC) 1–2 at 90 days. 
Complete recovery (CPC 1) was among secondary outcomes.
Results: In total, 300 patients were analyzed and the proportion with CPC 1–2 at 90 days was 35/150 (23.3%) in 
the intervention group versus 24/150 (16%) in the control group, odds ratio (OR) 1.92, 95% confidence interval (CI) 
0.95–3.85, p = .07. In patients with shockable rhythm, CPC 1–2 was 29/57 (50.9%) versus 17/57 (29.8%), OR 3.25, 95%, 
CI 1.06–9.97, p = .04. The proportion with CPC 1 at 90 days was 31/150 (20.7%) in the intervention group and 17/150 
(11.3%) in controls, OR 2.27, 95% CI 1.12–4.62, p = .02. In patients with shockable rhythms, the proportion with CPC 1 
was 27/57 (47.4%) versus 12/57 (21.1%), OR 5.33, 95% CI 1.55–18.3, p = .008.
Conclusions: In the whole study population, intra‑arrest cooling initiated < 20 min from collapse compared to 
cooling initiated at hospital was not associated with improved favorable neurologic outcome. In the subgroup with 
shockable rhythms, early cooling was associated with improved favorable outcome and complete recovery.
Keywords: Intra‑arrest, Therapeutic hypothermia, Out‑of‑hospital cardiac arrest, Neurological outcome, Transnasal 
cooling
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Introduction
Severe brain injury remains the primary cause of death 
in resuscitated cardiac arrest patients, while the strate-
gies currently available to improve neurologic outcome 
are limited [1–5]. Therapeutic hypothermia reduces 
ischemia–reperfusion brain injury after cardiac arrest 
by a number of mechanisms in experimental models 
[6]. This is especially true when early intra-arrest hypo-
thermia [i.e., cooling initiated during cardiopulmonary 
resuscitation (CPR)] is compared to delayed cooling ini-
tiated after return of spontaneous circulation (ROSC) 
[7–12]. Despite these laboratory findings, the vast major-
ity of clinical studies have assessed the effect of delayed 
therapeutic hypothermia when cooling has been initiated 
after hospital arrival, often several hours after the cardiac 
arrest [13–15]. The delayed timing of hypothermia in 
recent clinical studies may not have adequately addressed 
the underlying pathophysiology of ischemia and reperfu-
sion, and thus, there is a risk that the optimal time win-
dow for the greatest effectiveness of hypothermia will be 
missed [13].
To induce therapeutic hypothermia during CPR is 
challenging in real-world clinical practice. While rapid 
infusion with cold intravenous fluids is feasible for most 
emergency medical services (EMS), this approach has 
been associated with increased rate of hemodynamic 
adverse events [16–18], most likely due to the volume 
load to the heart and reduction in coronary perfusion 
pressure [19, 20]. In particular, these adverse events have 
been observed in patients with initial shockable rhythm 
(i.e., ventricular fibrillation or pulseless ventricular tachy-
cardia [17].
In the recent PRINCESS trial, 677 bystander-witnessed 
out-of-hospital cardiac arrest (OHCA) patients were ran-
domized to intra-arrest transnasal evaporative cooling or 
cooling started after hospital arrival. Transnasal evapora-
tive cooling is a method to induce hypothermia without 
adding a volume load to the heart, primarily targeting 
rapid cooling of the brain [21–23]. In the study, time to 
reach target core body temperature of < 34°C was signifi-
cantly shortened in the intra-arrest cooling group. The 
difference in survival with favorable neurologic outcome, 
Cerebral Performance Category (CPC) 1–2, was 16.6% vs 
13.5% (p = 0.25) in favor of the intra-arrest cooling group. 
In patients with shockable rhythms, CPC 1–2 survival 
was 34.8% in the intra-arrest cooling group vs 25.9% in 
controls (p = 0.11). [24].
Although early intra-arrest therapeutic hypothermia 
was targeted in the PRINCESS trial, the median time 
from collapse to start of intra-arrest cooling was 19 min 
which may have been too long for optimal neurologic 
outcome. Thus, the fact that about 50% of the patients 
in the intervention group had intra-arrest cooling initi-
ated later than 20 min from the collapse may have influ-
enced the overall results. The main hypothesis of this 
study was that the earlier intra-arrest therapeutic hypo-
thermia could be initiated, the better effect on mitigating 
ischemia and reperfusion injuries and thereby improving 
neurologic outcome among survivors.
The aim of this secondary analysis of the PRINCESS 
trial data was to investigate the association between the 
group of OHCA patients who received earlier initiation 
(i.e., < 20  min from collapse) of intra-arrest therapeu-




A prespecified sub-analysis of data from the PRINCESS 
trial [22], a European multicenter randomized clini-
cal trial comparing the effects of transnasal evapora-
tive intra-arrest cooling when compared to standard 
advanced life support (ALS) and subsequent cooling 
after hospital arrival in bystander-witnessed OHCA 
(Trial registration: NCT01400373). Randomization in 
the PRINCESS trial was generated in blocks of 4 without 
stratification on subgroups. Primary outcome was sur-
vival with favorable neurologic outcome, defined as CPC 
1–2, at 90 days [24].
A secondary analysis with regard to time to cooling 
was prespecified in the study protocol [22]. Initially, a 
cut of time of 15  min to initiate cooling from the col-
lapse was considered feasible and within the time 
period where many of the key mechanisms for pri-
mary brain injury are induced [6, 9, 22, 24]. However, 
this time point was changed post hoc from 15  min 
to < 20 min (i.e., median time to initiate cooling in the 
PRINCESS trial) as too few patients actually received 
intra-arrest cooling within 15 min from collapse to per-
form a statistically appropriate analysis. Thus, in this 
secondary analysis, hypothermia initiated within the 
median time to start cooling in the PRINCESS trial was 
used to define early cooling (i.e. < 20 min from cardiac 
arrest). Ethics and institutional committees in each 
Take‑home message 
Intra‑arrest cooling initiated by the emergency medical services 
within 20 min from cardiac arrest was associated with improved 
favorable neurologic outcome and complete recovery in patients 
with initial shockable rhythms. These results entirely match the 
concept of intra‑arrest cooling seen in experimental trials, and to 
our knowledge, this is the first time that this association has been 
shown in a clinical trial. No outcome differences were seen in 
patients with initial non‑shockable rhythms.
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participating country approved the study protocol as 
previously described. Written informed consent was 
obtained from the closest relative or a legal representa-
tive after hospital admission and from each patient who 
regained mental capacity.
Patients
We included bystander-witnessed OHCA patients ran-
domized in the PRINCESS trial. Exclusion criteria were 
age ≥ 80 years of age; known terminal disease; an existing 
do-not-resuscitate order; severe bleeding; EMS response 
time (collapse to EMS arrival) > 15  min; ROSC prior to 
randomization; pregnancy; hypothermia at time of evalu-
ation; or an anatomical barrier to place the intra-nasal 
catheters. In this sub-analysis assessing early cooling, we 
excluded patients in the intervention group where cool-
ing had been started after ≥ 20  min from the cardiac 
arrest (i.e., after the median time to start cooling in the 
PRINCESS trial), and patients randomized to the inter-
vention group, but did not receive intra-arrest cooling.
Treatment protocol and outcome assessment
After airway management (i.e., endotracheal intubation 
or laryngeal mask), patients were screened for eligibil-
ity and randomized by EMS to intra-arrest cooling dur-
ing ALS, or standard ALS. In most of the study sites, the 
cooling device was in the second tier. Transnasal evapo-
rative cooling is a noninvasive method where intranasal 
catheters are used to deliver a chemically inert cooling 
liquid perfluorohexane mixed with oxygen or air. The 
method was developed to primarily cool the brain 
[21–23]. Admitted patients were treated with hypother-
mia to 32–34°C for 24  h, regardless of randomization 
assignment.
Prehospital data were collected by the ALS team 
according to the Utstein template [25]. Neurologic out-
come assessment at 90  days was performed by a struc-
tured telephone interview or person-to-person using the 
CPC scale [26], where CPC 1 represents good recovery 
(alert with normal cerebral function), CPC 2, moderate 
disability (alert with sufficient cerebral function to live 
independently and work in a sheltered environment), 
CPC 3, severe disability (conscious but dependent on oth-
ers for daily support), CPC 4, vegetative state (any degree 
of coma without the presence of all brain death criteria) 
and CPC 5, dead. EMS or hospital personnel were not 
blinded to treatment due to nature of the intervention. 
Nurses/physicians performing neurological assessment 
at 90 days as well as data managers and researchers were 
blinded to the patients’ group assignment.
Outcomes
Primary outcome was survival with favorable neuro-
logic outcome (CPC 1–2) at 90  days. Secondary out-
comes were overall survival at 90 days and survival with 
complete neurologic recovery (CPC 1) at 90 days. The 
outcome of CPC 1 at 90 days was added post hoc in the 
main study [24]. Additional post hoc end points were 
CPC 1–2 in different time intervals (i.e., 0–9, 10–19, 
20–29, ≥ 30 min).
Statistical analysis
Continuous variables not normally distributed are 
reported as medians and interquartile ranges. Categori-
cal variables are reported as counts and percentages. 
In the primary analysis, patients with time to start of 
intra-arrest cooling < 20 min were analyzed, i.e., within 
the median time to start cooling in the PRINCESS trial. 
Propensity score matching (1:1) using nearest neighbor 
with a caliper width of 0.2 was used to find correspond-
ing patients in the control group and to balance covari-
ates between these groups. Variables included in the 
propensity score calculations were ‘time to randomiza-
tion’, age, gender, bystander CPR, initial rhythm, study 
site, etiology and patient weight. Time to randomiza-
tion was used as the matching time stamp. ‘Time to 
randomization’ had the highest correlation with ‘time 
to cooling’ (0.93). Balance between covariates before 
and after matching was compared using standardized 
mean difference (SMD). Conditional logistic regres-
sion was used for the main outcome analyses. Multiple 
imputations were not performed because there were 
no missing values for the primary, secondary or post 
hoc outcomes. Patients included in the primary analy-
sis had complete data in variables used for propensity 
score matching.
Furthermore, a crude comparison between groups was 
made based on the time from cardiac arrest to randomi-
zation where patients were divided into different time 
intervals (i.e., 0–9, 10–19, 20–29, ≥ 30  min). Patients 
with initial shockable and non-shockable rhythms were 
predefined subgroups. Thus, the data sets are presented 
in the following groups: all patients; patients with initial 
shockable rhythm; and patients with initial non-shocka-
ble rhythm. All probability values were two-sided, with 
values less than 0.05 regarded as statistically significant. 
Because of the potential for type I error due to multiple 
comparisons, findings for analyses of secondary and post 
hoc end points should be interpreted as exploratory. Sta-
tistical analyses were performed with the method R soft-
ware (version 3.6.0). For matching, the MatchIt package 




Among the 343 patients randomized to intra-arrest cool-
ing in the PRINCESS trial, 156 patients with complete 
study variables had cooling initiated < 20  min from the 
arrest. Out of these, propensity score matching (1:1) 
could be performed in 150 patients with correspond-
ing patients in the control group, and thus, 300 patients 
were included in the primary analysis (see Fig. 1). Base-
line characteristics before and after propensity score 
matching in patients (all patients and patients with ini-
tial shockable and non-shockable rhythm) are presented 
in Table 1. The time to target temperature (< 34 °C) was 
significantly shorter in patients receiving intra-arrest 
cooling (Table 1). The rate of ROSC was similar between 
groups (STable  1). Additional patient characteristics are 
presented in STable 1.
Primary outcome
After propensity score matching, the proportion of 
patients with favorable neurological outcome, CPC 1–2, 
at 90 days were 23.3% in the intervention group vs 16% 
in the control group, conditional odds ratio (OR) 1.92, 
95% CI 0.95–3.85, p = 0.068 for all patients (Table 2 and 
Fig.  2). In the subgroup of patients with initial shock-
able rhythm, the proportions of patients with CPC 1–2 
were 50.9% in the intervention group versus 29.8% in the 
control group, conditional OR 3.25, 95% CI 1.06–9.97, 
p = 0.039 (Fig.  2). In the subgroup of patients with ini-
tial non-shockable rhythm, the proportions with CPC 
1–2 were 6.5% in the intervention group versus 7.5% in 
the control group, conditional OR 1.33, 95% CI 0.3–5.96, 
p = 0.71 (Fig. 2). Kaplan Meier curves on the probability 
of survival with CPC 1–2 at 90 days are presented in Sup-
plement (SFigure 1 and 2).
Secondary outcomes
The proportions of patients with complete neurologi-
cal outcome (CPC 1) at 90 days were 20.7% in the inter-
vention group vs 11.3% in the control group, conditional 
odds ratio (OR) 2.27, 95% CI 1.12–4.62, p = 0.023 for all 
patients (Fig. 2). In the subgroup of patients with initial 
shockable rhythm, the proportions with CPC 1 were 
47.4% in the intervention group versus 21.1% in the 
control group, conditional OR 5.33, 95% CI 1.55–18.3, 
p = 0.008 (Fig. 2). In the subgroup of patients with initial 
non-shockable rhythm, the proportions with CPC 1 were 
4.3% in the intervention group versus 5.4% in the control 
group, conditional OR 0.67, 95% CI 0.11–3.99, p = 0.66 
(Fig. 2).
The proportions of patients alive at 90  days were 
24.7% in the intervention group vs 19.3% in the control 
group, conditional odds ratio (OR) 1.57, 95% CI 0.80–
3.07, p = 0.19 for all patients (Fig. 2). In the subgroup of 
patients with initial shockable rhythm, the proportions 
alive at 90 days were 52.6% in the intervention group ver-
sus 38.6% in the control group, conditional OR 1.92, 95% 
CI 0.68–4.96, p = 0.23 (Fig. 2). In the subgroup of patients 
with initial non-shockable rhythm, the proportions alive 
Fig. 1 Patients’ randomization flowchart
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Table 1 Baseline characteristics prior to  randomization and  times to  target temperature before  and after  propensity 
score matching
The patient populations are all patients and the subgroup of patients with initial shockable (i.e., ventricular fibrillation and ventricular tachycardia) and non-shockable 
(asystole and pulseless electric activity) rhythms
*Standard mean deviation; **interquartile range; ***emergency medicine service
Before matching After matching
Control Intervention SMD* Control Intervention SMD
All patients
n 334 165 150 150
Age, median [IQR**] 66 [56, 72] 63 [55, 72] 0.108 66 [58, 72] 63 [55, 71] 0.156
Sex, women n (%) 81 (24.3) 39 (23.6) 0.016 36 (24) 36 (24)  < 0.001
Height (mean (SD)) 175 (8) 175 (10) 0.030 175.22 (8.38) 175.31 (8.28) 0.010
Weight (mean (SD)) 85 (17) 82 (15) 0.187 85.99 (17.54) 82.01 (15.05) 0.243
Location, at home, n (%) 198 (64.7) 82 (53.9) 0.220 81 (60.4) 75 (54.3) 0.124
Bystander CPR, n (%) 194 (59.7) 97 (59.9) 0.004 85 (56.7) 89 (59.3) 0.054
Shockable rhythms (%) 135 (40.4) 64 (38.8) 0.033 57 (38) 57 (38)  < 0.001
Time to EMS*** CPR, min (median [IQR]) 9 (6, 12) 7 (6, 9) 0.504 7 (6, 10) 7 (6, 9) 0.098
Time to ALS, (median [IQR]) 13 (9, 17) 10 (8, 12) 0.689 10 (8, 13) 10 (8, 12) 0.091
Time to airway, min (median [IQR]) 14 (11, 17) 11 (9, 14) 0.602 12 (10, 14) 12 (10, 14) 0.008
Time to randomization, min (median [IQR]) 15 [12, 20] 13 [11, 15] 0.780 13 [11, 15] 13 [11, 15] 0.025
Time to tymp. temperature < 34°C, min, median [IQR] 149 (110, 215) 82 (64, 101) p < 0.001 157 (112, 198) 84 (65, 102) p < 0.001
Time to core body temperature < 34°C, min, median [IQR] 182 (132, 312) 94 (75, 111) p < 0.001 157 (136, 250) 95 (78, 111) p < 0.001
Patients with shockable rhythms
n 135 64 57 57
Age, median [IQR] 64 [57, 70] 61 [54, 68] 0.161 63 [58, 69] 60 [53, 68] 0.224
Sex, women n (%) 19 (14.2) 8 (12.5) 0.049 7 (12.3) 8 (14) 0.052
Height (mean (SD)) 177 (7) 178 (7) 0.208 178 (7) 178 (7) 0.034
Weight (mean (SD)) 85 (18) 85 (12) 0.008 87 (21) 85 (13) 0.130
Location, at home, n (%) 68 (56.2) 23 (38.3) 0.364 25 (51) 21 (39.6) 0.230
Bystander CPR, n (%) 99 (76.2) 44 (71) 0.118 46 (80.7) 41 (71.9) 0.207
Time to EMS CPR, min (median [IQR]) 9 (7, 13) 7 (5, 9) 0.678 8 (6, 11) 7 (6, 9) 0.242
Time to ALS, (median [IQR]) 13 (9, 18) 9 (7, 12) 0.824 10 (7, 14) 9 (7, 12) 0.309
Time to airway, min (median [IQR]) 14 (10, 17) 11 (8, 14) 0.594 11 (8, 14) 12 (9, 14) 0.041
Time to randomization, min (median [IQR]) 16 [12, 21] 13 [11, 15] 0.861 13 [10, 15] 13 [11, 15] 0.062
Time to tymp. temperature < 34°C, min, median [IQR] 144 (108, 264) 82 (65, 102) p < 0.001 136 (106, 254) 82 (65, 104) p < 0.001
Time to core body temperature < 34°C, min, median [IQR] 236 (158, 415) 96 (77, 110) p < 0.001 182 (140, 266) 96 (78, 139) p < 0.001
Patients with non‑shockable rhythms
n 199 101 93 93
Age, median [IQR] 66 [56, 73] 64 [56, 73] 0.082 67 [58, 74] 64 [56, 74] 0.121
Sex, women n (%) 62 (31.2) 31 (30.7) 0.010 29 (31.2) 28 (30.1) 0.023
Height (mean (SD)) 174 (9) 173 (11) 0.140 173.79 (8.8) 173.7 (8.68) 0.011
Weight (mean (SD)) 86 (17) 81 (16) 0.303 85.43 (15.18) 80.36 (16.15) 0.324
Location, at home, n (%) 130 (70.3) 59 (64.1) 0.131 56 (65.9) 54 (63.5) 0.049
Bystander CPR, n (%) 95 (48.7) 53 (53) 0.086 39 (41.9) 48 (51.6) 0.195
Time to EMS CPR, min (median [IQR]) 8 (6,12) 7 (6, 9) 0.418 7 (6, 9) 7 (6, 9) 0,009
Time to ALS, (median [IQR]) 12 (9, 17) 10 (8, 12) 0.595 10 (8, 13) 10 (8, 13) 0.081
Time to airway, min (median [IQR]) 13 (11, 17) 11 (10, 14) 0.608 12 (10, 14) 12 (10, 14) 0.033
Time to randomization, min (median [IQR]) 15 [12, 20] 13 [11, 14] 0.723 13 [11, 15] 14 [11, 15]  < 0.001
Time to tymp. temperature < 34°C, min, median [IQR] 157 (121, 202) 84 (62, 100) p < 0.001 164 (130, 196) 85 (66, 99) p < 0.001
Time to core body temperature < 34°C, min, median [IQR] 152 (125, 202) 93 (69, 114) p < 0.001 156 (134, 196) 93 (78, 104) p < 0.001
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Table 2 Outcomes before and after propensity score matching
The patient populations are all patients and the subgroup of patients with initial shockable (i.e., ventricular fibrillation and ventricular tachycardia) and non-shockable 
(asystole and pulseless electric activity) rhythms
*Fisher’s exact test
a p value after  chi2 test, bp value in the conditional logistic regression
Before matching After matching
Control Intervention P  chia Control Intervention P  chia, P  clogb
All patients
n 334 165 150 150
CPC 1–2 at 90 days, n (%) 45 (13.5) 38 (23) 0.007 24 (16) 35 (23.3) 0.110, 0.068
CPC 1 at 90 days, n (%) 35 (10.5) 34 (20.6) 0.002 17 (11.3) 31 (20.7) 0.041, 0.023
Survival at 90 days, n (%) 53 (15.9) 40 (24.2) 0.024 29 (19.3) 37 (24.7) 0.264, 0.186
Patients with shockable rhythms
n 135 64 57 57
CPC 1–2 at 90 days, n (%) 35 (25.9) 32 (50)  < 0.001 17 (29.8) 29 (50.9) 0.020, 0.039
CPC 1 at 90 days, n (%) 27 (20) 30 (46.9)  < 0.0001 12 (21.1) 27 (47.4) 0.003, 0.008
Survival at 90 days, n (%) 42 (31.1) 33 (51.6) 0.005 22 (38.6) 30 (52.6) 0.132, 0.232
Patients with non‑shockable rhythms
n 199 101 93 93
CPC 1–2 at 90 days, n (%) 10 (5) 6 (5.9) 0.738 7 (7.5) 6 (6.5) 1.000*, 0.706
CPC 1 at 90 days, n (%) 8 (4) 4 (4) 1.000* 5 (5.4) 4 (4.3) 1.000*, 0.657
Survival at 90 days, n (%) 11 (5.5) 7 (6.9) 0.628 7 (7.5) 7 (7.5) 1.000, 0.706
Fig. 2 Primary and secondary outcomes in the adjusted analysis presented with odds ratio (OR) and 95% confidence interval (CI). The patient 
populations are all patients and the subgroup of patients with initial shockable (i.e., ventricular fibrillation and ventricular tachycardia) and non‑
shockable (asystole and pulseless electric activity) rhythms
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at 90  days were 7.5% in the intervention group versus 
7.5% in the control group, conditional OR 1.33, 95% CI 
0.3–5.96, p = 0.71 (Fig. 2).
In Fig.  3, crude outcome data (i.e., survival with 
CPC 1–2 and CPC 1) are presented in different patient 
groups depending on the time to randomization. Pre-
dicted probability of CPC score and corresponding 
interaction p value between time to randomization are 
presented in Supplement (SFigure 3).
Discussion
In this secondary analysis of the PRINCESS trial where 
patients were randomized at the scene of the arrest to 
intra-arrest cooling versus standard ALS and subsequent 
initiation of systemic cooling at hospital, we assessed a 
potential association between time to initiate intra-arrest 
cooling before 20  min from the collapse and survival 
with favorable neurologic outcome (CPC1-2) at 90 days. 
There are several potentially important findings of the 
study. First, the difference observed in favorable neuro-
logic outcome at 90 days was not statistically significant 
in the whole patient cohort. Second, in the subgroup of 
patients with initial shockable rhythms, early intra-arrest 
cooling is associated with improved favorable neurologic 
outcome, whereas no difference is seen in patients with 
non-shockable rhythms. Third, there are significant dif-
ferences in complete neurologic outcome in the whole 
patient cohort, but with the most apparent differences 
in patients with initial shockable rhythm. Fourth, intra-
arrest transnasal evaporative cooling was not associated 
with decreased rate of ROSC which has been the case of 
earlier intra-arrest studies when cooling has been per-
formed with cold fluids. Thus, early, intra-arrest cooling 
per se does not seem convey hemodynamic side effects 
if you use a method that does not add volume load to the 
heart.
Crucial knowledge gaps remain regarding how to 
attenuate reperfusion brain injury after cardiac arrests. 
The pathophysiologic mechanisms following ROSC are 
triggered promptly; in clinical practice, this means prior 
to hospital arrival. The immediate injuries caused by 
ischemia will deplete intracellular ATP within minutes 
Fig. 3 Survival with good neurologic outcome, CPC 1–2, in different time groups depending on the time to randomization in all patients and in 
patients with initial shockable rhythm
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inducing several pathophysiologic pathways [6]. Within 
15  min of reperfusion, formation of free oxygen radi-
cals and dysfunctional calcium regulation promote 
subsequent damage to cellular membranes and altera-
tions in cerebral blood flow [6]. Thus, therapeutic strat-
egies to mitigate brain injury in this population may be 
more effective if established during resuscitation itself or 
immediately following ROSC.
A key question for clinicians is whether there is a time 
window for best effectiveness of therapeutic hypother-
mia in cardiac arrest as suggested in prior experimen-
tal studies [8–10, 12]. The approach to assess the effect 
of therapeutic hypothermia was different in PRINCESS 
compared to most previous studies. In the pragmatic 
TTM trial, there was a four-hour window allowed from 
ROSC (not collapse) to randomization (not initiation 
of treatment) [13]. This could be an important meth-
odological issue when trying to reduce the highly time-
sensitive ischemic and reperfusion brain injury after 
cardiac arrest. In this earlier cooling subgroup analysis 
with bystander-witnessed OHCA, we observed a signal 
toward a higher rate of favorable neurologic outcome and 
complete recovery in patients where intra-arrest cooling 
had been initiated < 20  min from collapse compared to 
standard care where cooling was initiated after hospital 
arrival. Although 20 min must be seen as an explorative 
time stamp, the results suggest that an earlier initiation 
of intra-arrest cooling in refractory cardiac arrest may 
improve the chance to influence neurologic outcome 
compared to cooling started after hospital arrival. The 
time to initiate cooling is different than the time required 
to reach the target temperature. In this population, the 
initiation of intra-arrest cooling reduced the time to 
reach target temperature significantly. We believe that 
this strategy of fast cooling is important even if the time 
interval to reach target temperature may vary for several 
reasons and could be confounded by the severity of the 
brain injury. Thus, patients with more extensive brain 
injuries may be easier to cool rapidly because they no 
longer have the compensatory physiology to defend core 
body temperature [27, 28].
Consistent with prior cardiac arrest trials, the vast 
majority of survivors in the current investigation were 
within the patient subgroup with initial shockable 
rhythms. It is also in this subgroup that a potential ben-
efit in neurologic outcomes with an earlier cooling initia-
tion was observed. In a recent study [29] of OHCA and 
in-hospital cardiac arrest patients with non-shockable 
rhythms, a benefit of therapeutic hypothermia initiated 
during intensive care was seen also in these patients 
compared to normothermia. We did not see any sig-
nal toward improved outcome in these patients. How-
ever, this population with non-shockable rhythms in the 
PRINCESS trial was randomized prior to ROSC which 
make direct comparisons difficult. When patients with 
non-shockable rhythms, especially asystole, are included 
in randomized cardiac arrest trials, the potential ben-
efit of a specific intervention may be masked due to the 
extreme poor chances of survival in that specific group 
[30]. Based on our data, further studies of intra-arrest 
cooling should focus primarily on the patients with initial 
shockable rhythms.
While many prior studies have grouped CPC 1 and 2 
outcomes, more granular analysis suggests potential dif-
ferences in outcome in the current cohort. When evalu-
ating CPC scores in the PRINCESS trial itself, there was 
a post hoc finding with a higher proportion of patients 
with CPC 1 in the intra-arrest cooling group among 
patients with initial shockable rhythms. The current sub-
analysis suggests that this potential benefit is more pro-
nounced in the patients that receive start of intra-arrest 
cooling within 20  min from collapse. Future studies 
should preferably include more subtle neurological and 
cognitive end points such as the modified Rankin Scale 
and Glasgow Coma Outcome Scale extended [31].
Limitations
This secondary analysis has several limitations. Firstly, 
we included patients from a randomized clinical trial 
where allocation of early versus late randomization per 
se was not randomized. Secondly, although the groups 
have similar baseline characteristics and propensity score 
matching was performed, the risk of residual confound-
ing needs to be acknowledged. Thirdly, although patients 
with shockable rhythms are a well-recognized subgroup 
in cardiac arrest studies, a subgroup analysis always 
introduces a risk of selection bias and may alter the gen-
eralizability of the results. Fourth, we have limited data 
on whether it was a presumed cardiac cause of the arrest 
or not. Finally, although the outcome assessors were 
blinded to the treatment allocation, the EMS and hospi-
tal personnel were not which may have influenced their 
management.
Conclusion
In the whole study population, intra-arrest cooling initi-
ated < 20 min from collapse compared to cooling initiated 
at hospital was not associated with improved favorable 
neurologic outcome. In the subgroup with shockable 
rhythms, early cooling was associated with improved 
favorable outcome and complete recovery. No outcome 
differences were seen in patients with initial non-shock-
able rhythms. The findings should be seen as hypothesis 
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